USPTO serial 99056009
PHARMAAND
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SHERMAN, GENEVA R
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with PHARMAAND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MATTHEW HOMYK
MATTHEW HOMYK BLANK ROME LLPOne Logan Square, 130 North 18th StreetPhiladelphia, PA 19103United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of mental health; Pharmaceutical preparations for the treatment of ulcerative colitis; Pharmaceutical preparations for the treatment of Crohn's disease; Pharmaceutical preparations for the treatment of overactive-bladder syndrome; Pharmaceutical preparations for the treatment of acute bronchial asthma attacks and reversible bronchospastic states associated with chronic bronchitis or emphysema; Pharmaceutical preparations for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical preparations for the treatment of hepatitis; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical agents affecting digestive organs; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of hematological diseases and disorders; Pharmaceutical preparations for the treatment of gastroenterological diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Antivirals | ACTIVE | — |
| 035 | Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies | ACTIVE | — |
| 042 | Drug discovery services; Pharmaceutical research and development; Providing information about medical and scientific research; Research and development and consultation related thereto in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Scientific research consulting; Scientific research consulting in the field of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 13, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 13, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 13, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 3, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 3, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 3, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 28, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 27, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 30, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 30, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 21, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 25, 2025 | NWAP | NEW APPLICATION ENTERED | — |